Ayano Kakiuchi, Shion Ito, S. Okuyama, Y. Furukawa, T. Mizuma
{"title":"Human serum albumin binding of 3, 5, 6, 7, 8, 3’, 4’- heptamethoxyflavone, a citrus flavonoid possessing a neuroprotective effect","authors":"Ayano Kakiuchi, Shion Ito, S. Okuyama, Y. Furukawa, T. Mizuma","doi":"10.1273/CBIJ.17.103","DOIUrl":"https://doi.org/10.1273/CBIJ.17.103","url":null,"abstract":"3, 5, 6, 7, 8, 3’, 4’-heptamethoxyflavone (HMF), which is present in citrus fruits, has been reported to induce brain-derived neurotropic factor (BDNF) production, and have an anti-inflammatory effect. However, its pharmacokinetics is obscure. Therefore, as the first study of HMF pharmacokinetics, the reversible binding of HMF to human serum albumin (HSA) has been examined. For the binding examination and further pharmacokinetic study of HMF, a simple HPLC assay method was established first. The HPLC system equipped with a UV detector (HPLC-UV) and an isocratic mobile phase were used. The accuracy of intra-assay validation at each concentration from 1 to 100 M was from 97.2 to 101.6%, and the precision of intra-assay validation was less than 1.60%. For inter-assay validation, the accuracy was from 97.1 to 104.5%, and the precision was less than 2.24% from 1 to 100 M of HMF. The reversible binding of HMF to HSA was performed by the equilibrium dialysis method. The bound fraction of HMF to 4.6% HSA decreased from around 70% to 55% as the total concentration of HMF increased. This concentration dependency of the reversible binding suggests that HMF may have a specific binding site on the HSA molecule. The HPLC method established in this study is now being used for further investigation of HMF pharmacokinetics, such as intestinal absorption.","PeriodicalId":40659,"journal":{"name":"Chem-Bio Informatics Journal","volume":"197 1","pages":"103-109"},"PeriodicalIF":0.3,"publicationDate":"2017-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75924076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Myths in Modern Science: The Hydrogen Bond and its Surroundings. Part 1. The Hydrogen-Bond-Myth","authors":"M. Nishio","doi":"10.1273/CBIJ.17.85","DOIUrl":"https://doi.org/10.1273/CBIJ.17.85","url":null,"abstract":"Widespread arguments of the hydrogen bond are criticized with respect to theories of protein folding and interactions of proteins with their specific ligands. Contrary to popular belief, by no means does the hydrogen bond play an important role in determining the conformation of proteins and the interactions of proteins with specific substrates. Stereotypical thinking on the hydrogen bond constitutes a myth in modern science and seriously restricts the success of structure-based drug design.","PeriodicalId":40659,"journal":{"name":"Chem-Bio Informatics Journal","volume":"183 1","pages":"85-92"},"PeriodicalIF":0.3,"publicationDate":"2017-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74621234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yuto Komeij, Yoshio Okiyama, Y. Mochizuki, Kaori Fukuzawa
{"title":"Explicit solvation of a single-stranded DNA, a binding protein, and their complex: a suitable protocol for fragment molecular orbital calculation","authors":"Yuto Komeij, Yoshio Okiyama, Y. Mochizuki, Kaori Fukuzawa","doi":"10.1273/CBIJ.17.72","DOIUrl":"https://doi.org/10.1273/CBIJ.17.72","url":null,"abstract":"Fragment molecular orbital (FMO) calculations were performed for explicitly solvated single-stranded DNA (ssDNA), ssDNA binding protein, and their complex in order to assess the solvent effects on the solutes and thereby to find optimal solvation conditions for FMO calculation. A series of solvated structures were generated with different solvent thicknesses. The structures were subjected to FMO calculation at MP2/6-31G* to obtain the net charges and internal energies of the solutes and the solute–solvent interaction energies as functions of the solvent thickness. In all cases, the properties showed complete or marginal convergence at ca. 6 Ǻ, regardless whether or not the system charge was neutralized. This suggested that the first and second solvent shells mainly determine the electronic structure of a solute while the outer solvent including ions has only minor effects, consistent with several preceding reports. In light of this, and considering safety as a factor, we conclude that a solvent shell thickness of ca. 8 Ǻ suffices for FMO calculation of the solutes.","PeriodicalId":40659,"journal":{"name":"Chem-Bio Informatics Journal","volume":"9 1","pages":"72-84"},"PeriodicalIF":0.3,"publicationDate":"2017-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77685062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Sato, Hitomi Yuki, C. Watanabe, J. Saito, A. Konagaya, T. Honma
{"title":"Prediction of the site of CYP3A4 metabolism of tolterodine by molecular dynamics simulation from multiple initial structures of the CYP3A4-tolterodine complex","authors":"A. Sato, Hitomi Yuki, C. Watanabe, J. Saito, A. Konagaya, T. Honma","doi":"10.1273/CBIJ.17.38","DOIUrl":"https://doi.org/10.1273/CBIJ.17.38","url":null,"abstract":"","PeriodicalId":40659,"journal":{"name":"Chem-Bio Informatics Journal","volume":"252 1","pages":"38-52"},"PeriodicalIF":0.3,"publicationDate":"2017-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77502178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Competitive fragment assay for the selective inhibitor of WNKs kinase","authors":"Nae Saito, Y. Tada, T. Okabe, T. Nagano","doi":"10.1273/CBIJ.17.34","DOIUrl":"https://doi.org/10.1273/CBIJ.17.34","url":null,"abstract":"Pseudohypoaldosteronism type II is a rare, familial, autosomal-dominant hypertensive disease that is caused by mutations of WNK (with no lysine [K]) protein kinases 1 and 4. WNKs lack a lysine residue in the 3 strand that is generally conserved in protein kinases. WNK 1 and WNK4 share 87% homology, and possess an unusual back pocket just behind the catalytic lysine residue (Lys233 in WNK1). Therefore, compounds interacting with both the back pocket and catalytic lysine residue could be selective inhibitors. Here, we screened a fragment library for inhibitors of WNK1-mediated phosphorylation by means of mobility shift assay and surface plasmon resonance (SPR)-based binding assay. Among the identified inhibitors, some interacted with the back pocket rather than the hinge region of WNK1, as determined by SPR competitive binding assay. The results of kinase profiling suggest these compounds are promising leads for development of selective inhibitors of WNK 1 and","PeriodicalId":40659,"journal":{"name":"Chem-Bio Informatics Journal","volume":"3 1","pages":"34-37"},"PeriodicalIF":0.3,"publicationDate":"2017-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82775341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Novel Fragment Recommendation Workflow using Direct and Indirect Transfer of SAR According to Integrated Similarities of Scaffold Motifs and SAR Trends: Application to Identifying Factor Xa Inhibitors","authors":"T. Ishihara, K. Mori, R. Munakata, Ayako Moritomo","doi":"10.1273/CBIJ.17.1","DOIUrl":"https://doi.org/10.1273/CBIJ.17.1","url":null,"abstract":"Here we report a new drug design workflow that facilitates the transfer of structure-activity relationships (SARs) and recommends alternative fragments from SAR databases. We first prepare two collections of matched molecular series (MMS) comprising a query set of compounds with their SARs and a set derived from reference SAR databases. The second step detects MMS from the reference SAR sources, which identifies profiles similar to a query MMS according to integrated similarities of scaffold shapes and SAR trends. The third step enumerates new compounds with improved activity profiles compared with a query compound computed using a collaborative filtering algorithm. Our workflow detected direct and latent relationships between a query MMS and those derived from the reference SAR sources. Retrospective application of this workflow to the identification of factor Xa inhibitors yielded recommendations with higher predictive accuracy than a conventional quantitative SAR technique. Moreover, potent S1 binding elements were identified using SAR knowledge independent of information about ligand-protein complexes.","PeriodicalId":40659,"journal":{"name":"Chem-Bio Informatics Journal","volume":"28 3 1","pages":"1-18"},"PeriodicalIF":0.3,"publicationDate":"2017-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91337036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Population Pharmacokinetic Parameter Estimates using a Limited Sampling Design: Analysis of Blood Alcohol Levels","authors":"Asuka Nemoto, Masaaki Matsuura, K. Yamaoka","doi":"10.1273/CBIJ.16.25","DOIUrl":"https://doi.org/10.1273/CBIJ.16.25","url":null,"abstract":"When population pharmacokinetic (PPK) analysis is conducted, there are often constraints on obtaining blood samples at multiple time points. In this context, it is a concern that estimated PPK parameters are reported without an evaluation of their reliability. The aim of the present study was to improve the reliability of the estimated population mean pharmacokinetic parameters after assessing the precision and accuracy of the estimates by stochastic simulation and estimation. In an example of alcohol metabolism data, where samples taken later than 60 min after consumption were not available, the precision of the estimates for the population mean elimination rate “constant” (kel) was found to be low. To tackle this problem, real-life data were aggregated with the data stochastically generated from historical knowledge, and the parameters were estimated. The estimated kel value based on only real data was revealed to be biased toward a lower value.","PeriodicalId":40659,"journal":{"name":"Chem-Bio Informatics Journal","volume":"1 1","pages":"25-39"},"PeriodicalIF":0.3,"publicationDate":"2016-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90371492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"In silico Analysis of Interactions between Nevirapine-related Compounds, HLA-B*14:02 and T-cell Receptor","authors":"Hideto Isogai, N. Hirayama","doi":"10.1273/CBIJ.16.9","DOIUrl":"https://doi.org/10.1273/CBIJ.16.9","url":null,"abstract":"A non-nucleoside reverse-transcriptase inhibitor nevirapine (NVP) used to treat HIV-1 infection can cause severe, life-threatening idiosyncratic drug toxicity (IDT). It is known that the IDT caused by NVP or its metabolites is associated with the HLA-B*14:02 haplotype. The molecular mechanism of the HLA -associated IDT, however, has not been disclosed. In this study, we have simulated the interaction modes between NVP-related compounds, HLA-B*14:02 , and a T-cell receptor in order to understand the molecular mechanism leading to the onset of IDT.","PeriodicalId":40659,"journal":{"name":"Chem-Bio Informatics Journal","volume":"IM-25 1","pages":"9-12"},"PeriodicalIF":0.3,"publicationDate":"2016-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84704576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"In silico Analysis of Interactions between HLA-A*31:01 and carbamazepine-related Compounds","authors":"H. Miyadera, T. Ozeki, T. Mushiroda, N. Hirayama","doi":"10.1273/CBIJ.16.5","DOIUrl":"https://doi.org/10.1273/CBIJ.16.5","url":null,"abstract":"Carbamazepine (CBZ) is a widely used anticonvulsant and is one of the major causative drugs of cutaneous adverse drug reactions (cADRs), such as Stevens-Johnson syndrome and toxic epidermal necrolysis. For the East Asians and Europeans HLA-A*31:01 is associated with CBZ-induced cADRs. We have undertaken in silico docking simulations of CBZ and its metabolites at the peptide-binding groove of HLA-A*31:01 in order to identify the chemical species responsible for the CBZ-induced cADR.","PeriodicalId":40659,"journal":{"name":"Chem-Bio Informatics Journal","volume":"24 1","pages":"5-8"},"PeriodicalIF":0.3,"publicationDate":"2016-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76703476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"In silico Analysis of Interactions between HLA-B*58:01 and Allopurinol-related Compounds","authors":"M. Osabe, M. Tohkin, N. Hirayama","doi":"10.1273/CBIJ.16.1","DOIUrl":"https://doi.org/10.1273/CBIJ.16.1","url":null,"abstract":"Allopurinol, the most traditional and widely used medication for hyperuricemia and gout, has been reported as a common cause of severe cutaneous adverse reactions. Allopurinol is rapidly and extensively metabolized to oxipurinol. At least six allopurinol-related impurities have been reported to be contained in allopurinol. It is of interest to identify the compound which is likely to be responsible to the adverse reactions. Since a strong association between allopurinol-induced adverse reactions and HLA-B*58:01 has been observed, binding of allopurinol-related compounds to HLA-B*58:01 must be important for the onset of the adverse reactions. In this study, using the three-dimensional structure of HLA-B*58:01 constructed by homology modeling, the binding modes and affinities between allopurinol-related compounds and HLA-B*58:01 were simulated by docking simulations. The results have indicated that the adverse reactions of allopurinol should be due very largely to oxipurinol. The results also suggested that the concentrations of several impurities currently approved by the United States Pharmacopeia should be strictly monitored not to exceed the limits because they may strongly bind to HLA-B*58:01 and possibly leading to more severe adverse reactions.","PeriodicalId":40659,"journal":{"name":"Chem-Bio Informatics Journal","volume":"18 1","pages":"1-4"},"PeriodicalIF":0.3,"publicationDate":"2016-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89436844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}